DocSym
β
Searchsearch
Search
(G23.1) Progressive supranuclear ophthalmoplegia [steele-richardson-olszewski]
More details coming soon
111 647 in individuals diagnosis progressive supranuclear ophthalmoplegia [steele-richardson-olszewski] confirmed
45 439 deaths with diagnosis progressive supranuclear ophthalmoplegia [steele-richardson-olszewski]
41% mortality rate associated with the disease progressive supranuclear ophthalmoplegia [steele-richardson-olszewski]
Diagnosis progressive supranuclear ophthalmoplegia [steele-richardson-olszewski] is diagnosed Men are 19.75% more likely than Women
66 848
Men receive the diagnosis progressive supranuclear ophthalmoplegia [steele-richardson-olszewski]
23 581 (35.3 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
44 799
Women receive the diagnosis progressive supranuclear ophthalmoplegia [steele-richardson-olszewski]
21 858 (48.8 %)Died from this diagnosis.
Risk Group for the Disease progressive supranuclear ophthalmoplegia [steele-richardson-olszewski] - Men and Women aged 65-69
In Men diagnosis is most often set at age 10-89
Less common in men the disease occurs at Age 0-9, 90-95+Less common in women the disease occurs at Age 0-1, 95+
In Women diagnosis is most often set at age 0-94
Disease Features progressive supranuclear ophthalmoplegia [steele-richardson-olszewski]
Absence or low individual and public risk
Progressive supranuclear ophthalmoplegia [steele-richardson-olszewski] - what does this mean
Progressive supranuclear ophthalmoplegia (steele-richardson-olszewski) is a progressive neurological disorder caused by the degeneration of neurons in the brainstem and basal ganglia. it is characterized by a slowly progressive decline in eye movement, balance, and coordination, as well as cognitive and behavioral changes. this disorder is typically caused by an accumulation of abnormal proteins in the brain, leading to the death of neurons and the eventual inability to control eye movements.
What happens during the disease - progressive supranuclear ophthalmoplegia [steele-richardson-olszewski]
Progressive supranuclear ophthalmoplegia (pso) is a degenerative neurological disorder caused by the progressive degeneration of neurons in the brain stem and basal ganglia. this leads to the disruption of the pathways that control eye movement, resulting in difficulty in controlling eye movements, blurred vision, and double vision. as the disease progresses, the patient may experience difficulty with balance, difficulty in walking, and cognitive decline.
Clinical Pattern
More details coming soon
How does a doctor diagnose
More details coming soon
Treatment and Medical Assistance
More details coming soon
33 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Progressive supranuclear ophthalmoplegia [steele-richardson-olszewski] - Prevention
Progressive supranuclear ophthalmoplegia (steele-richardson-olszewski) is a degenerative neurological disorder that affects the eyes and can lead to vision loss. prevention of this disorder is largely focused on lifestyle changes, such as eating a balanced diet, exercising regularly, and avoiding smoking and excessive alcohol consumption. additionally, regular check-ups with a doctor to monitor for any changes in vision or other symptoms can help to identify the disorder in its early stages and allow for timely interventions.